These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32462787)

  • 1. Accrual, Publication Bias, and the Coronavirus in 2020.
    Bates SE
    Oncologist; 2020 Jul; 25(7):e1001-e1002. PubMed ID: 32462787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial.
    Segelov E; Prenen H; Day D; Macintyre CR; Foo EMJ; Ali R; Wang Q; Wei X; Lopes GL; Ding K; Chen G; Chia JWK; Toh HC;
    JCO Glob Oncol; 2020 Apr; 6():585-588. PubMed ID: 32293940
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
    Moskowitz CS; Panageas KS
    JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
    [No Abstract]   [Full Text] [Related]  

  • 4. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 5. The Virtual Match: A New Approach to Celebrating Students During Social Distancing Due to COVID-19.
    Boysen-Osborn M; Youm J; Le-Bucklin KV
    Acad Med; 2020 Nov; 95(11):e8-e9. PubMed ID: 32769443
    [No Abstract]   [Full Text] [Related]  

  • 6. The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing.
    MacKay MJ; Hooker AC; Afshinnekoo E; Salit M; Kelly J; Feldstein JV; Haft N; Schenkel D; Nambi S; Cai Y; Zhang F; Church G; Dai J; Wang CL; Levy S; Huber J; Ji HP; Kriegel A; Wyllie AL; Mason CE
    Nat Biotechnol; 2020 Sep; 38(9):1021-1024. PubMed ID: 32820257
    [No Abstract]   [Full Text] [Related]  

  • 7. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.
    Assaker R; Colas AE; Julien-Marsollier F; Bruneau B; Marsac L; Greff B; Tri N; Fait C; Brasher C; Dahmani S
    Br J Anaesth; 2020 Sep; 125(3):e330-e332. PubMed ID: 32534738
    [No Abstract]   [Full Text] [Related]  

  • 8. Questions asked through two examples of dilemmas of publication ethics in the process of COVID-19.
    Tanriverdi O; Ozcan M
    Med Oncol; 2020 Aug; 37(10):86. PubMed ID: 32833094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Covid-19, the Société française du cancer (SFC) and the BulletinduCancer].
    Rodrigues M
    Bull Cancer; 2020 Apr; 107(4):393-394. PubMed ID: 32334674
    [No Abstract]   [Full Text] [Related]  

  • 10. Digitalized Adaptation of Oncology Trials during and after COVID-19.
    Li G; Yin C; Zhou Y; Wang T; Chen J; Liu Y; Chen T; Wang H; Zhang L; Chen X
    Cancer Cell; 2020 Aug; 38(2):148-149. PubMed ID: 32634378
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncology Practice During the COVID-19 Pandemic.
    Schrag D; Hershman DL; Basch E
    JAMA; 2020 May; 323(20):2005-2006. PubMed ID: 32282023
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic.
    Marron JM; Joffe S; Jagsi R; Spence RA; Hlubocky FJ
    J Clin Oncol; 2020 Jul; 38(19):2201-2205. PubMed ID: 32343643
    [No Abstract]   [Full Text] [Related]  

  • 13. Audio Interview: A New Monoclonal Antibody for Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(18):e117. PubMed ID: 33113304
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Board: Our Multidisciplinary Cutaneous Oncology Tumor Board During the Coronavirus-19 Pandemic.
    Chow M; Jiang SIB
    Dermatol Surg; 2020 Sep; 46(9):1224-1225. PubMed ID: 32740206
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 research: promising tracks leading to uro-oncology.
    Tamás F; Tibor S; Anita C; Boris H; Péter N
    Int Urol Nephrol; 2020 Jun; 52(6):995-997. PubMed ID: 32394243
    [No Abstract]   [Full Text] [Related]  

  • 16. The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials.
    Bagiella E; Bhatt DL; Gaudino M
    J Am Coll Cardiol; 2020 Jul; 76(3):342-345. PubMed ID: 32470514
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on 'Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey' by Alice Indini et al.
    Bongiovanni A; Mercatali L; Fausti V; Ibrahim T
    Eur J Cancer; 2020 Jul; 134():3-5. PubMed ID: 32425366
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
    Usmani SS; Raghava GPS
    Front Immunol; 2020; 11():561851. PubMed ID: 33133071
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies for Maintaining Educational Standards in Medical Oncology Residency Training in the Era of COVID-19: Experience from a Canadian Cancer Centre.
    Arora R; Mukherjee SD
    J Cancer Educ; 2020 Dec; 35(6):1068-1069. PubMed ID: 32970302
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Gynaecological oncology diseases during COVID-19 global pandemic.
    de Andrade Vieira M; Araujo RLC
    Eur J Surg Oncol; 2020 Jun; 46(6):1182-1183. PubMed ID: 32359918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.